Annual review date: 2016
This topic was identified for update following the annual review of quality standards in 2014. The review identified that there had been changes in the areas for improvement for breast cancer and new guidance published on familial breast cancer.
This NICE quality standard defines clinical best practice within this topic area. It provides specific, concise quality statements, measures and audience descriptors to provide the public, health and social care professionals, commissioners and service providers with definitions of high-quality care.
This quality standard covers the management of early (ductal carcinoma in situ and invasive), locally advanced and advanced breast cancer in adults. This includes the management of both screen-detected and symptomatic breast cancers from the point of referral to a specialist team. The scope does not include adults with rare breast tumours, benign breast disease, lobular carcinoma in situ, or the care of women with an increased risk of breast cancer due to family history.
This quality standard was previously called breast cancer quality standard.